GetTopicDetailResponse(id=9e2c12566e12, topicName=奧瑞利珠單抗注射液, introduction=, content=多發(fā)性硬化癥 奧瑞利珠單抗注射液, image=null, comments=0, allHits=247, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Tue Apr 01 11:55:30 CST 2025, time=2025-04-01, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=503110, tagList=[TagDto(tagId=503110, tagName=奧瑞利珠單抗注射液)], ipAttribution=, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2258662, encodeId=d37f225866248, content=<a href='/topic/show?id=d2ca4310374' target=_blank style='color:#2F92EE;'>#多發(fā)性硬化癥#</a> <a href='/topic/show?id=9e2c12566e12' target=_blank style='color:#2F92EE;'>#奧瑞利珠單抗注射液#</a>, objectTitle=一年注射兩次！羅氏制藥羅可適?在華獲批用于治療復發(fā)型和原發(fā)進展型多發(fā)性硬化癥, objectType=article, longId=869967, objectId=4f6486996e46, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250221/1740101200194_8538692.jpg, objectUrl=/article/show_article.do?id=4f6486996e46, replyNumber=0, likeNumber=34, createdTime=2025-04-01, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f6486996e46, moduleTitle=一年注射兩次！羅氏制藥羅可適?在華獲批用于治療復發(fā)型和原發(fā)進展型多發(fā)性硬化癥, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4f6486996e46)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-04-01
